Street analysts say diabetes stocks ‘overreacting’ to Lilly GLP-1 study results
PremiumThe FlyStreet analysts say diabetes stocks ‘overreacting’ to Lilly GLP-1 study results
29d ago
Diabetes stock selloff on Lilly Surmount-1 results overdone, says Citi
Premium
The Fly
Diabetes stock selloff on Lilly Surmount-1 results overdone, says Citi
29d ago
Insulet opens new manufacturing facility in Malaysia
Premium
The Fly
Insulet opens new manufacturing facility in Malaysia
1M ago
Insulet price target lowered to $250 from $270 at BTIG
PremiumThe FlyInsulet price target lowered to $250 from $270 at BTIG
1M ago
Insulet price target raised to $223 from $211 at UBS
Premium
The Fly
Insulet price target raised to $223 from $211 at UBS
1M ago
Closing Bell Movers: Expedia rallies 10% on earnings beat
Premium
The Fly
Closing Bell Movers: Expedia rallies 10% on earnings beat
1M ago
Stifel sees ‘unexpected diabetes tech marriage’ as negative for DexCom, others
PremiumThe FlyStifel sees ‘unexpected diabetes tech marriage’ as negative for DexCom, others
1M ago
Insulet (PODD) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Insulet (PODD) Q2 Earnings Cheat Sheet
1M ago
Insulet sees Q2 revenue $488M, consensus $460.27M
Premium
The Fly
Insulet sees Q2 revenue $488M, consensus $460.27M
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100